NCT03170440 Non-invasive Nerve Stimulation for PTSD and Sleep
| NCT ID | NCT03170440 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Post Traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 221 participants |
| Start Date | 2017-11-01 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 221 participants in total. It began in 2017-11-01 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, our objective is to determine the effect of two different nerve stimulation types in changing sleep architecture.
Eligibility Criteria
Inclusion Criteria: * veterans with history of PTSD with and without history of mild TBI Exclusion Criteria with: * history of severe psychiatric illness unrelated to PTSD or TBI * other medical conditions of severity that may impair cognition * current illicit or prescription drug abuse * breathing disorder requiring constant use of oxygen
Contact & Investigator
John Williamson, Ph.D.
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT03170440 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03170440 currently recruiting?
Yes, NCT03170440 is actively recruiting participants. Contact the research team at john.williamson2@va.gov for enrollment information.
Where is the NCT03170440 trial being conducted?
This trial is being conducted at Gainesville, United States, Gainesville, United States, Jacksonville, United States.
Who is sponsoring the NCT03170440 clinical trial?
NCT03170440 is sponsored by University of Florida. The principal investigator is John Williamson, Ph.D. at University of Florida. The trial plans to enroll 221 participants.